BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38246515)

  • 1. Carnitine functions as an enhancer of NRF2 to inhibit osteoclastogenesis via regulating macrophage polarization in osteoporosis.
    Yang T; Liu S; Ma H; Lai H; Wang C; Ni K; Lu Y; Li W; Hu X; Zhou Z; Lou C; He D
    Free Radic Biol Med; 2024 Mar; 213():174-189. PubMed ID: 38246515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.
    Gong W; Liu M; Zhang Q; Zhang Q; Wang Y; Zhao Q; Xiang L; Zheng C; Zhang Q; Qin L
    Oxid Med Cell Longev; 2022; 2022():5410377. PubMed ID: 35585885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
    Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
    FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
    Chen D; Ye Z; Wang C; Wang Q; Wang H; Kuek V; Wang Z; Qiu H; Yuan J; Kenny J; Yang F; He J; Liu Y; Wang G; Zhang M; Zhang G; Wang J; Chen P; Xu J
    Pharmacol Res; 2020 Sep; 159():104944. PubMed ID: 32454224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening identified natural Keap1-Nrf2 PPI inhibitor alleviates inflammatory osteoporosis through Nrf2-mir214-Traf3 axis.
    Hong J; Shi Z; Li C; Ji X; Li S; Chen Y; Jiang G; Shi M; Wang W; Zhang Y; Hu B; Yan S
    Free Radic Biol Med; 2021 Aug; 171():365-378. PubMed ID: 34000381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
    Kanzaki H; Shinohara F; Kajiya M; Kodama T
    J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
    Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q
    J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17β-estradiol plays the anti-osteoporosis role via a novel ESR1-Keap1-Nrf2 axis-mediated stress response activation and Tmem119 upregulation.
    Yang R; Li J; Zhang J; Xue Q; Qin R; Wang R; Goltzman D; Miao D
    Free Radic Biol Med; 2023 Feb; 195():231-244. PubMed ID: 36592659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production.
    Miao J; Tu Y; Jiang J; Ren R; Wu Q; Liang H; Wang T; Lin B; Wu J; Pan Y; Wang X; Jin H
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129357. PubMed ID: 38216011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrroloquinoline quinone alleviates natural aging-related osteoporosis via a novel MCM3-Keap1-Nrf2 axis-mediated stress response and Fbn1 upregulation.
    Li J; Zhang J; Xue Q; Liu B; Qin R; Li Y; Qiu Y; Wang R; Goltzman D; Miao D; Yang R
    Aging Cell; 2023 Sep; 22(9):e13912. PubMed ID: 37365714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency.
    Yang R; Zhang J; Li J; Qin R; Chen J; Wang R; Goltzman D; Miao D
    Free Radic Biol Med; 2022 Jan; 178():246-261. PubMed ID: 34890768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis.
    Xu Y; Song D; Su Y; Chen J; Wu L; Lian H; Hai N; Li J; Jiang J; Zhao J; Xu J; Liu Q
    Biomed Pharmacother; 2023 Mar; 159():114101. PubMed ID: 36640671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
    Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
    Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFα-induced osteoclastogenesis by mediating ROS generation.
    Reziwan K; Sun D; Zhang B; Zhao Z
    Cell Biochem Funct; 2019 Jun; 37(4):256-265. PubMed ID: 31017694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
    Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
    Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urolithin A attenuates RANKL-induced osteoclastogenesis by co-regulating the p38 MAPK and Nrf2 signaling pathway.
    Wei W; Peng C; Gu R; Yan X; Ye J; Xu Z; Sheng X; Huang G; Guo Y
    Eur J Pharmacol; 2022 Apr; 921():174865. PubMed ID: 35231470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss.
    Guo J; Ren R; Guo Z; Sun K; He J; Shao J; Wang X
    Int Immunopharmacol; 2023 Mar; 116():109820. PubMed ID: 36758295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation.
    Feng X; Liu Z; Su Y; Lian H; Gao Y; Zhao J; Xu J; Liu Q; Song F
    Biochem Pharmacol; 2023 Dec; 218():115895. PubMed ID: 38084677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
    Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
    Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.